Vor Biopharma Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. And good afternoon. My name is Carter Gould, senior biopharma analyst here at Barclays. Welcome to day 3 of the Barclays Global Healthcare Conference. I'm pleased to welcome CEO, Robert Ang, of Vor Biopharma to the virtual stage here.
Robert, thank you very much for joining us today. You're going to give a presentation. We're looking forward to it. We recently initiated on Vor, really transformative approach to addressing potentially a number of diseases, but certainly AML is the forefront right now.
So with that, I will turn it over to Robert. Thanks again.
Thank you very much, Carter, and for the opportunity to present at this conference. And so as Carter mentioned, we are trying to take a totally different view on cancer and cancer targets. And we'll show you a platform that we're using, which is built around what we call engineered hematopoietic stem cells, eHSCs. Now these are the same cells that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
